{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:29:05Z","timestamp":1784366945116,"version":"3.55.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1097\/mpa.0000000000000625","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T13:50:21Z","timestamp":1464875421000},"page":"1179-1183","source":"Crossref","is-referenced-by-count":11,"title":["A Randomized Comparative Study of 24- and 6-Hour Infusion of Nafamostat Mesilate for the Prevention of Post\u2013Endoscopic Retrograde Cholangiopancreatography Pancreatitis"],"prefix":"10.1097","volume":"45","author":[{"given":"Su Jin","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Hwan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol Woong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Bum","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong Jun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeong Seok","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210212","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJM199609263351301","article-title":"Complications of endoscopic biliary sphincterotomy","volume":"335","author":"Freeman","year":"1996","journal-title":"N Engl J Med"},{"key":"R2-16-20210212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0016-5107(98)70121-X","article-title":"Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study","volume":"48","author":"Loperfido","year":"1998","journal-title":"Gastrointest Endosc"},{"key":"R3-16-20210212","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1572-0241.2001.03594.x","article-title":"Complications of diagnostic and therapeutic ERCP: a prospective multicenter study","volume":"96","author":"Masci","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R4-16-20210212","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.gie.2011.07.010","article-title":"Complications of ERCP","volume":"75","author":"Anderson","year":"2012","journal-title":"Gastrointest Endosc"},{"key":"R5-16-20210212","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00006676-199105000-00013","article-title":"ERCP- and endoscopic sphincterotomy-induced pancreatitis","volume":"6","author":"Sherman","year":"1991","journal-title":"Pancreas"},{"key":"R6-16-20210212","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1515\/bchm2.1978.359.2.1653","article-title":"Secretin\/cholecystokinin-stimulated secretion of trypsinogen and trypsin inhibitor in pure human pancreatic juice collected by endoscopic retrograde catheterization","volume":"359","author":"Eddeland","year":"1978","journal-title":"Hoppe Seylers Z Physiol Chem"},{"key":"R7-16-20210212","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1067\/msy.2001.115827","article-title":"Regional effects of nafamostat, a novel potent protease and complement inhibitor, on severe necrotizing pancreatitis","volume":"130","author":"Keck","year":"2001","journal-title":"Surgery"},{"key":"R8-16-20210212","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s00535-013-0834-x","article-title":"Pharmacologic prophylaxis of post\u2013endoscopic retrograde cholangiopancreatography pancreatitis: protease inhibitors and NSAIDs in a meta-analysis","volume":"49","author":"Yuhara","year":"2014","journal-title":"J Gastroenterol"},{"key":"R9-16-20210212","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/MPA.0b013e31822116d5","article-title":"Is high-dose nafamostat mesilate effective for the prevention of post-ERCP pancreatitis, especially in high-risk patients?","volume":"40","author":"Park","year":"2011","journal-title":"Pancreas"},{"key":"R10-16-20210212","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/MPA.0000000000000278","article-title":"Randomized controlled trial for efficacy of nafamostat mesilate in preventing post\u2013endoscopic retrograde cholangiopancreatography pancreatitis","volume":"44","author":"Ohuchida","year":"2015","journal-title":"Pancreas"},{"key":"R11-16-20210212","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0016-5107(91)70740-2","article-title":"Endoscopic sphincterotomy complications and their management: an attempt at consensus","volume":"37","author":"Cotton","year":"1991","journal-title":"Gastrointest Endosc"},{"key":"R12-16-20210212","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1067\/mge.2001.117550","article-title":"Risk factors for post-ERCP pancreatitis: a prospective, multicenter study","volume":"54","author":"Freeman","year":"2001","journal-title":"Gastrointest Endosc"},{"key":"R13-16-20210212","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.cgh.2014.11.038","article-title":"Evaluation of pharmacologic prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a systematic review","volume":"13","author":"Kubiliun","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R14-16-20210212","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1111\/j.1572-0241.2003.07698.x","article-title":"Comparison of two dosing regimens of gabexate in the prophylaxis of post-ERCP pancreatitis","volume":"98","author":"Masci","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R15-16-20210212","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJM199609263351302","article-title":"Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in Digestive Endoscopy\u2014Italian Group","volume":"335","author":"Cavallini","year":"1996","journal-title":"N Engl J Med"},{"key":"R16-16-20210212","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0016-5107(02)70431-8","article-title":"Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial","volume":"56","author":"Andriulli","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"R17-16-20210212","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1542-3565(04)00295-2","article-title":"Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate","volume":"2","author":"Andriulli","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R18-16-20210212","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.gie.2007.02.055","article-title":"Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study","volume":"65","author":"Manes","year":"2007","journal-title":"Gastrointest Endosc"},{"key":"R19-16-20210212","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1590\/S0100-879X2006000100010","article-title":"Clinical trial of gabexate in the prophylaxis of post\u2013endoscopic retrograde cholangiopancreatography pancreatitis","volume":"39","author":"Xiong","year":"2006","journal-title":"Braz J Med Biol Res"},{"key":"R20-16-20210212","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.gie.2006.10.030","article-title":"Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis","volume":"65","author":"Andriulli","year":"2007","journal-title":"Gastrointest Endosc"},{"key":"R21-16-20210212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0016-5107(00)70377-4","article-title":"Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis","volume":"51","author":"Andriulli","year":"2000","journal-title":"Gastrointest Endosc"},{"key":"R22-16-20210212","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1440-1746.2007.04928.x","article-title":"Somatostatin and gabexate for post\u2013endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled trials","volume":"22","author":"Rudin","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"R24-16-20210212","first-page":"2600","article-title":"Preventive effect of ulinastatin and gabexate mesylate on post\u2013endoscopic retrograde cholangiopancreatography pancreatitis","volume":"123","author":"Zhang","year":"2010","journal-title":"Chin Med J (Engl"},{"key":"R25-16-20210212","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-230X-7-6","article-title":"Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials","volume":"7","author":"Zheng","year":"2007","journal-title":"BMC Gastroenterol"},{"key":"R26-16-20210212","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.curtheres.2008.08.001","article-title":"Gabexate mesylate in the prevention of post\u2013endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and meta-analysis update","volume":"69","author":"Zheng","year":"2008","journal-title":"Curr Ther Res Clin Exp"},{"key":"R27-16-20210212","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3109\/00365519109104564","article-title":"Distribution and elimination of intravenously injected urinary trypsin inhibitor","volume":"51","author":"Jonsson-Berling","year":"1991","journal-title":"Scand J Clin Lab Invest"},{"key":"R28-16-20210212","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S1542-3565(04)00671-8","article-title":"Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial","volume":"3","author":"Tsujino","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R29-16-20210212","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/MPA.0b013e31817f528f","article-title":"Preventive effects of ulinastatin on post\u2013endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a prospective, randomized, placebo-controlled trial","volume":"37","author":"Yoo","year":"2008","journal-title":"Pancreas"},{"key":"R30-16-20210212","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1254\/jjp.41.155","article-title":"Pharmacological studies of FUT-175, nafamostat mesilate. V. Effects on the pancreatic enzymes and experimental acute pancreatitis in rats","volume":"41","author":"Iwaki","year":"1986","journal-title":"Jpn J Pharmacol"},{"key":"R31-16-20210212","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.gie.2008.10.046","article-title":"Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis","volume":"69","author":"Choi","year":"2009","journal-title":"Gastrointest Endosc"},{"key":"R32-16-20210212","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/MPA.0b013e3181f94d46","article-title":"Nafamostat mesilate for prevention of post\u2013endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized, double-blind, controlled trial","volume":"40","author":"Yoo","year":"2011","journal-title":"Pancreas"},{"key":"R33-16-20210212","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1055\/s-0034-1377875","article-title":"Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) guideline\u2014updated June 2014","volume":"46","author":"Dumonceau","year":"2014","journal-title":"Endoscopy"},{"key":"R34-16-20210212","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/apt.12534","article-title":"Systematic review with network meta-analysis: pharmacological prophylaxis against post-ERCP pancreatitis","volume":"38","author":"Akshintala","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"R35-16-20210212","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00535-008-2272-8","article-title":"Epinephrine sprayed on the papilla for prevention of post-ERCP pancreatitis","volume":"44","author":"Matsushita","year":"2009","journal-title":"J Gastroenterol"},{"key":"R36-16-20210212","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1440-1746.2011.06718.x","article-title":"Prevention of post\u2013endoscopic retrograde cholangiopancreatography pancreatitis by epinephrine sprayed on the papilla","volume":"26","author":"Xu","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"R37-16-20210212","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0016-5107(99)70385-8","article-title":"Same-day discharge after endoscopic biliary sphincterotomy: observations from a prospective multicenter complication study. The Multicenter Endoscopic Sphincterotomy (MESH) Study Group","volume":"49","author":"Freeman","year":"1999","journal-title":"Gastrointest Endosc"},{"key":"R38-16-20210212","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00464-009-0832-5","article-title":"Is outpatient ERCP suitable, feasible, and safe? The experience of a Spanish community hospital","volume":"24","author":"Rabago","year":"2010","journal-title":"Surg Endosc"},{"key":"R39-16-20210212","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0016-5107(97)70263-3","article-title":"Therapeutic ERCP in outpatients","volume":"45","author":"Tham","year":"1997","journal-title":"Gastrointest Endosc"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000000625","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:41:15Z","timestamp":1620963675000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006676-201609000-00016"}},"subtitle":["A Prospective Randomized Comparison Trial"],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0000000000000625","relation":{},"ISSN":["0885-3177"],"issn-type":[{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}